Impact of patient and clinical characteristics on cognitive changes after allogeneic hematopoietic stem cell transplantation
November 2, 2021
In this longitudinal study of patients hematologic cancers, Drs. Nakamura, Rosenstein, and colleagues identified that cognitive impairment was common over the 6 months following stem cell transplantation. However, cognition incrementally improved among study participants over time and, of importance, more severe disease and aggressive prior treatment did not impede this...